LITTLE FALLS, N.J.,
Sept. 1, 2016 /PRNewswire/
-- CANTEL MEDICAL CORP. (NYSE:CMN) is pleased to
announce that Seth M. Yellin has
recently been promoted to Executive Vice President, Strategy and
Corporate Development from Senior Vice President, Corporate
Development. In his new role, Mr. Yellin will have
responsibility for Cantel's strategic planning function along with
his current role of corporate development, which includes leading
the Company's active acquisition program.
Jorgen Hansen, Cantel's President
and Chief Executive Officer stated, "Seth is the ideal candidate to
lead the expanded strategic planning function for Cantel. He's
played an integral role in the development of our past two
five-year strategic plans and this responsibility goes hand-in-hand
with his excellent leadership of our acquisition
program."
Mr. Yellin joined Cantel Medical in April, 2012 as Vice
President, Corporate Development. He received a BA from
Princeton University and an MBA from
The Wharton School at the University of
Pennsylvania.
About Cantel Medical
Cantel Medical is a leading
global company dedicated to delivering innovative infection
prevention products and services for patients, caregivers, and
other healthcare providers which improve outcomes, enhance safety
and help save lives. Our products include specialized medical
device reprocessing systems for endoscopy and renal dialysis,
advanced water purification equipment, sterilants, disinfectants
and cleaners, sterility assurance monitoring products for hospitals
and dental clinics, disposable infection control products primarily
for dental and GI endoscopy markets, dialysate concentrates, hollow
fiber membrane filtration and separation products. Additionally, we
provide technical service for our products. For further
information, visit the Cantel website at www.cantelmedical.com.
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These statements involve a number of risks and uncertainties,
including, without limitation, the risks detailed in Cantel's
filings and reports with the Securities and Exchange Commission.
Such forward-looking statements are only predictions, and actual
events or results may differ materially from those projected or
anticipated.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cantel-medical-promotes-seth-m-yellin-to-executive-vice-president-300321345.html
SOURCE Cantel Medical Corp.